Brian Concannon has sold CNMD and made no open-market buys since Sep 2020

Brian P. Concannon is a corporate director and healthcare industry executive who has served as a Director of CONMED Corporation (NASDAQ: CNMD) since July 2013.( At CONMED, he brings more than three decades of leadership experience in medical technology, sales, and operations, drawing on his prior role as President and Chief Executive Officer of Haemonetics Corporation, a global blood management company headquartered in Braintree, Massachusetts.( He is considered an independent director under Securities and Exchange Commission rules.(

Concannon joined Haemonetics in 2003 and progressed through senior roles including President, Patient Division; President, Global Markets; Chief Operating Officer; and, in 2009, President and CEO while also serving on Haemonetics’ board of directors.( Before Haemonetics, he held regional and leadership positions at Cardinal Health Medical Products and Services, American Hospital Supply Corporation, Baxter Healthcare, and Allegiance Healthcare, building deep experience in sales, marketing, and operations within the healthcare sector.( A 1979 graduate of the United States Military Academy at West Point with a B.S. in engineering, he began his career as an officer in the U.S. Army and has since served in additional governance and civic roles, including on the board of South Shore Health and as Civilian Aide to the Secretary of the Army for Massachusetts.(

Written by Perplexity from public sources.